Real ‐world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma

ConclusionIn this study, responses to combination immunotherapy were lower than reported. Patients treated with prior immunotherapy had similar responses as treatment ‐naïve pts. The toxicity profile seen in this study is similar to those reported in clinical trials.

Source: Asia-Pacific Journal of Clinical Oncology - November 13, 2018 Category: Cancer & Oncology Authors: Sagun Parakh, Manreet Randhawa, Bella Nguyen, Lydia Warburton, Mohammad Akhtar Hussain, Jonathan Cebon, Michael Millward, Desmond Yip, Sayed Ali Tags: ORIGINAL ARTICLE Source Type: research